NLRP3 and colitis: Studies demonstrate that the activation of NLRP3 may improve the prognosis of IBDs-mice infected with H. pylori, which exhibits less severity of DSS-induced colitis, and characterized by notably reduced inflammation and less epithelial alterations (Kim et al., 2013).